Literature DB >> 1493848

Pharmacokinetics and effects of atrial natriuretic factor during hypothermic cardiopulmonary bypass.

M Hynynen1, K T Olkkola, R Palojoki, I Tikkanen, F Fyhrquist.   

Abstract

The pharmacokinetics of a bolus dose of synthetic atrial natriuretic factor (ANF) 50 micrograms and its effects on urine output, blood pressure and plasma renin activity have been studied in 5 patients undergoing hypothermic cardiopulmonary bypass for cardiac surgery. The half-lives of the fast and slow components were 2.4 min and 14.2 min, respectively. The volume of the central compartment was 16.7 l and the volume of distribution at steady-state was 38.9 l. The total plasma clearance was 3.8 l.min-1. ANF significantly increased urine output and decreased blood pressure, but it did not affect plasma renin activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1493848     DOI: 10.1007/bf02284966

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  23 in total

1.  Physiological role of silent receptors of atrial natriuretic factor.

Authors:  T Maack; M Suzuki; F A Almeida; D Nussenzveig; R M Scarborough; G A McEnroe; J A Lewicki
Journal:  Science       Date:  1987-10-30       Impact factor: 47.728

Review 2.  Role of endopeptidase-24.11 in the inactivation of atrial natriuretic peptide.

Authors:  A J Kenny; S L Stephenson
Journal:  FEBS Lett       Date:  1988-05-09       Impact factor: 4.124

Review 3.  Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis.

Authors:  J H Laragh
Journal:  N Engl J Med       Date:  1985-11-21       Impact factor: 91.245

4.  Pharmacokinetics of synthetic atrial natriuretic peptides in normal men.

Authors:  J Biollaz; L T Callahan; J Nussberger; B Waeber; H J Gomez; E H Blaine; H R Brunner
Journal:  Clin Pharmacol Ther       Date:  1987-06       Impact factor: 6.875

5.  Plasma atrial natriuretic peptide in cardiac disease and during infusion in healthy volunteers.

Authors:  I Tikkanen; F Fyhrquist; K Metsärinne; R Leidenius
Journal:  Lancet       Date:  1985-07-13       Impact factor: 79.321

6.  Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in man.

Authors:  T G Yandle; A M Richards; M G Nicholls; R Cuneo; E A Espiner; J H Livesey
Journal:  Life Sci       Date:  1986-05-19       Impact factor: 5.037

7.  Plasma concentration of alpha-hANP and renal responses to alpha-hANP infusion in patients with congestive heart failure and those with chronic renal failure.

Authors:  Y Hirata; M Ishii; H Matsuoka; T Sugimoto; M Iizuka; T Serizawa; O Kohmoto; T Sugimoto; A Miyata; K Kangawa
Journal:  Jpn Circ J       Date:  1988-12

8.  Effect of hypothermia on drug metabolism. In vitro studies with propranolol and verapamil.

Authors:  R G McAllister; T G Tan
Journal:  Pharmacology       Date:  1980       Impact factor: 2.547

9.  Effects and pharmacokinetics of bolus injections of atrial natriuretic factor in normal volunteers.

Authors:  J R Cusson; P Du Souich; P Hamet; E L Schiffrin; O Kuchel; J Tremblay; M Cantin; J Genest; P Larochelle
Journal:  J Cardiovasc Pharmacol       Date:  1988-06       Impact factor: 3.105

Review 10.  Cardiopulmonary bypass and the pharmacokinetics of drugs. An update.

Authors:  W A Buylaert; L L Herregods; E P Mortier; M G Bogaert
Journal:  Clin Pharmacokinet       Date:  1989-07       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.